伊金金对帕金森病患者的认知和运动功能的有效性:随机对照试验的研究协议
Kailiang Luo1,2, Xinran Ma3, Xueming Jin4
1Department of Rehabilitation, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Frontiers in neurology
|May 13, 2024
概括
炼运动在改善帕金森病 (PD) 患者的运动和认知功能方面表现有前途. 这项研究评估了与快步和对照组相比,它的有效性和潜在机制.
科学领域:
- 神经科学是一个神经科学.
- 康复医学 康复医学 康复医学
- 老年学是一门学科.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,影响运动和非运动功能,显著降低生活质量.
- 目前用于PD的药物治疗方法的有效性有限.
- 非药物干预措施,如炼,为PD患者的认知和运动功能提供了潜在的好处,但需要有力的证据.
研究的目的:
- 为了评估在帕金森病患者中,Yijinjing运动干预措施的临床疗效.
- 探索将炼与PD认知和运动功能的改善联系在一起的潜在机制.
- 为了比较健炼与快步和对照组的效果.
主要方法:
- 一个单中心随机对照试验,涉及96名符合条件的PD患者.
- 参与者被随机分配到炼运动,快速步行或对照组 (1:1:1比).
- 干预措施 (40分钟的会议,每周3次,持续12周) 包括对认知 (MoCA) 和运动 (UPDRS-III) 功能,平衡,执行功能,行走,睡眠和生活质量进行评估,并对前额叶皮层血液氧气进行监测.
主要成果:
- 该研究方案旨在提供高质量的证据,证明炼对PD的影响.
- 预期的结果将突出表现出PD患者进行炼的认知和活动水平的改善.
- 将研究对大脑活动变化的机制性见解.
结论:
- 炼是一种潜在的非药物治疗方法来治疗帕金森病.
- 这种干预可能为PD患者提供一种新且有效的治疗策略.
- 进一步的研究将巩固Yijinjing练习作为PD管理的有价值组成部分.
相关概念视频
01:24Parkinson's Disease: Treatment
263
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
263
01:15Parkinson's Disease: Overview
533
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
533
01:22Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
01:37Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K